Home » Abbott Receives Emergency Use Authorization for COVID-19 Test
Abbott Receives Emergency Use Authorization for COVID-19 Test
Abbott has been granted an Emergency Use Authorization (EUA) by the FDA for use of its coronavirus molecular test on its Alinity m molecular diagnostics analyzer.
The company is currently launching the Alinity m analyzer, which received FDA marketing clearance in March for use with its hepatitis C assay.
The automated platform can run up to 1,080 tests in 24 hours. In contrast, Abbott’s m 2000 RealTime system can only process 480 tests in a day.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May